Browse > Article
http://dx.doi.org/10.3344/kjp.2010.23.1.65

Ganglion Impar Block With Botulinum Toxin Type A for Chronic Perineal Pain -A Case Report-  

Lim, Su-Jin (Department of Anesthesiology and Pain Medicine, The Catholic University of Korea College of Medicine)
Park, Hue-Jung (Department of Anesthesiology and Pain Medicine, The Catholic University of Korea College of Medicine)
Lee, Sang-Hoon (Department of Anesthesiology and Pain Medicine, The Catholic University of Korea College of Medicine)
Moon, Dong-Eon (Department of Anesthesiology and Pain Medicine, The Catholic University of Korea College of Medicine)
Publication Information
The Korean Journal of Pain / v.23, no.1, 2010 , pp. 65-69 More about this Journal
Abstract
Chronic perineal pain is an often encountered problem, which produces a great degree of functional impairment and frustration to the patient and a challenge to the treating physician. The reason for this problem is that the region contains diverse anatomic structures with mixed somatic, visceral and autonomic innervations affecting bladder and bowel control and sexual function. A blockade of nociceptive and sympathetic supply to the perineal region, supplied through the ganglion impar has been shown to benefit patients with chronic perineal pain. Several options to this block have been described that chemical neurolysis, radiofrequency ablation etc. Although the analgesic effect of Botulinum toxin type A (BoNT-A) has long been considered secondary to its action for muscle relaxation, BoNT-A also affects the release of the neurotransmitters that are involved in pain perception. We describe a patient who was successfully given ganglion impar block with BoNT-A.
Keywords
botulinum toxin type A; ganglion impar;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Mahant N, Clouston PD, Lorentz IT. The current use of botulinum toxin. J Clin Neurosci 2000; 7: 389-94.   DOI   ScienceOn
2 Aoki KR. Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache 2003; 43(Suppl 1): 9-15.   DOI   ScienceOn
3 Park HJ, Lee Y, Lee J, Park C, Moon DE. The effects of botulinum toxin A on mechanical and cold allodynia in a rat model of neuropathic pain. Can J Anaesth 2006; 53: 470-7.   DOI   ScienceOn
4 Swift A. The current uses of botulinum toxin. Hosp Med 2003; 64: 450-1.   DOI
5 Radensky PW, Archer JW, Dournaux SF, O'Brien CF. The estimated cost of managing focal spasticity: a physician practice patterns survey. Neurorehabil Neural Repair 2001; 15: 57-68.   DOI   ScienceOn
6 Mailis A, Furlan A. Sympathectomy for neuropathic pain. Cochrane Database Syst Rev 2003; 2: CD002918.
7 Ranoux D, Attal N, Morain F, Bouhassira D. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain. Ann Neurol 2008; 64: 274-83.   DOI   ScienceOn
8 Arezzo JC. Possible mechanisms for the effects of botulinum toxin on pain. Clin J Pain 2002; 18(6 Suppl): 125-32.   DOI
9 Bach-Rojecky L, Lackovic Z. Central origin of the antinociceptive action of botulinum toxin type A. Pharmacol Biochem Behav 2009; 94: 234-8.   DOI   ScienceOn
10 Kim HJ, Seo K, Yum KW, Oh YS, Yoon TG, Yoon SM. Effects of botulinum toxin type A on the superior cervical ganglia in rabbits. Auton Neurosci 2002; 102: 8-12.   DOI   ScienceOn
11 Ailani J, Young WB. The role of nerve blocks and botulinum toxin injections in the management of cluster headaches. Curr Pain Headache Rep 2009; 13: 164-7.   DOI   ScienceOn
12 Carroll I, Clark JD, Mackey S. Sympathetic block with botulinum toxin to treat complex regional pain syndrome. Ann Neurol 2009; 65: 348-51.   DOI   ScienceOn
13 Lee HK, Yang SK, Lee HJ, Lee SY, Kim SM, Kim BS, et al. The effect of ganglion impar block for excessive perianal sweating. Korean J Pain 1995; 8: 363-6.
14 Jin L, Kollewe K, Krampfl K, Dengler R, Mohammadi B. Treatment of phantom limb pain with botulinum toxin type A. Pain Med 2009; 10: 300-3.   DOI   ScienceOn
15 Welch MJ, Purkiss JR, Foster KA. Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins. Toxicon 2000; 38: 245-58.   DOI   ScienceOn
16 Cui M, Khanijou S, Rubino J, Aoki KR. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain 2004; 107: 125-33.   DOI   ScienceOn
17 Tait RC, Chibnall JT, Krause S. The pain disability index: psychometric properties. Pain 1990; 40: 171-82.   DOI   ScienceOn
18 Toshniwal GR, Dureja GP, Prashanth SM. Transsacrococcygeal approach to ganglion impar block for management of chronic perineal pain: a prospective observational study. Pain Physician 2007; 10: 661-6.
19 Reig E, Abejon D, del Pozo C, Insausti J, Contreras R. Thermocoagulation of the ganglion impar or ganglion of Walther: description of a modified approach. Preliminary results in chronic, nononcological pain. Pain Pract 2005; 5: 103-10.   DOI   ScienceOn
20 Kim SK, Ahn CS, Cho YR, Lim SY, Shin KM, Hong SY, et al. Ganglion impar block in the management of rectal tenesmoid pain. Korean J Pain 1996; 9: 226-8.